1. Home
  2. RNXT vs LGL Comparison

RNXT vs LGL Comparison

Compare RNXT & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • LGL
  • Stock Information
  • Founded
  • RNXT 2012
  • LGL 1917
  • Country
  • RNXT United States
  • LGL United States
  • Employees
  • RNXT N/A
  • LGL N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • LGL Industrial Machinery/Components
  • Sector
  • RNXT Health Care
  • LGL Technology
  • Exchange
  • RNXT Nasdaq
  • LGL Nasdaq
  • Market Cap
  • RNXT 31.6M
  • LGL 31.5M
  • IPO Year
  • RNXT 2021
  • LGL N/A
  • Fundamental
  • Price
  • RNXT $1.03
  • LGL $6.89
  • Analyst Decision
  • RNXT Strong Buy
  • LGL
  • Analyst Count
  • RNXT 1
  • LGL 0
  • Target Price
  • RNXT $9.00
  • LGL N/A
  • AVG Volume (30 Days)
  • RNXT 207.2K
  • LGL 4.2K
  • Earning Date
  • RNXT 03-31-2025
  • LGL 03-31-2025
  • Dividend Yield
  • RNXT N/A
  • LGL N/A
  • EPS Growth
  • RNXT N/A
  • LGL 66.76
  • EPS
  • RNXT N/A
  • LGL 0.07
  • Revenue
  • RNXT N/A
  • LGL $4,130,000.00
  • Revenue This Year
  • RNXT N/A
  • LGL N/A
  • Revenue Next Year
  • RNXT N/A
  • LGL N/A
  • P/E Ratio
  • RNXT N/A
  • LGL $95.59
  • Revenue Growth
  • RNXT N/A
  • LGL 26.49
  • 52 Week Low
  • RNXT $0.77
  • LGL $4.86
  • 52 Week High
  • RNXT $1.86
  • LGL $7.00
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 31.77
  • LGL 56.39
  • Support Level
  • RNXT $1.32
  • LGL $6.50
  • Resistance Level
  • RNXT $1.18
  • LGL $7.00
  • Average True Range (ATR)
  • RNXT 0.10
  • LGL 0.26
  • MACD
  • RNXT -0.04
  • LGL -0.03
  • Stochastic Oscillator
  • RNXT 6.00
  • LGL 85.33

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

Share on Social Networks: